Aurobindo PharmaShare price targets & analyst calls

Sector:Pharmaceuticals & Biotechnology

₹1,716-5.50 (-0.32%)

As of 24 Sept 2026

Analysts lean BUY·9 of 10 long-term calls BUY·consensus 1Y target ₹1,706 (0.6% below CMP)

₹1,706

0.6% below CMP

₹950 – ₹1,900

10 active 1Y targets

13 open

11 BUY · 2 SELL (all horizons)

41%

36 of 87 closed calls hit

Watch AUROPHARMA for new buy/sell callsGet alerts See 59 Pharmaceuticals & Biotechnology sector analyst picks

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

What’s happening with the stock

Technicals

Not investment advice.

Technical indicators

63.5

Neutral

+5.3% (₹1,629.77)

Bullish

+22.4% (₹1,402.5)

Bullish

1.0% below high · 60.3% above low

Context

820K · 1.0×

Above avg

Technical indicators are computed from exchange prices. Not investment advice.

All tips · page 3 of 3

← Back to filtered view

BUYAUROPHARMAAurobindo PharmaIntradayExpired

-0.34% realisedNA upside left

₹1,575.8

At expiry

₹1,545

Entry

₹1,581.2

Target

₹1,600

expired 30 Jun 2026, 3:20 pm

KBKunal Bothra· via Zee Business (Live)12w ago

BUYAUROPHARMAAurobindo PharmaIntradayExpired○ No trade

— realisedNA upside left

₹1,470

Entry

₹1,490

Target

₹1,530

ASAmit Seth· via CNBC Awaaz.15w ago

Showing 101–102 of 102